| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2004 | CA2280850C Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| 01/13/2004 | CA2242224C Sustained-release microgranules containing diltiazem as the active principle |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/13/2004 | CA2139731C 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 01/13/2004 | CA2102630C Pharmaceutical compositions of compacted medicaments |
| 01/13/2004 | CA2076664C Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 01/13/2004 | CA2053359C Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 01/11/2004 | CA2391596A1 Antibiotics as a treatment for dementia |
| 01/08/2004 | WO2004003555A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 01/08/2004 | WO2004003545A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 01/08/2004 | WO2004003544A1 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 01/08/2004 | WO2004003215A1 Method of isolating biologically active fraction containing clinically acceptable native slipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |
| 01/08/2004 | WO2004003201A2 Antisense modulation of lrh1 expression |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004003145A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | WO2004003121A1 Desinfecting composition |
| 01/08/2004 | WO2004003002A1 Novel adenosine analogues and their use as pharmaceutical agents |
| 01/08/2004 | WO2004003000A2 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections |
| 01/08/2004 | WO2004002999A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 01/08/2004 | WO2004002998A1 Method for the separation of triglycoalkaloids |
| 01/08/2004 | WO2004002992A1 Compounds |
| 01/08/2004 | WO2004002991A1 Porphyrin-polyamine conjugates for cancer therapy |
| 01/08/2004 | WO2004002987A1 Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain |
| 01/08/2004 | WO2004002978A1 Refreshment capable of stimulating movement of digestive tract |
| 01/08/2004 | WO2004002967A1 Difluorothioacetamides of oxazolidinones as antibacterial agents |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002963A1 Amide derivative |
| 01/08/2004 | WO2004002962A1 Novel benzimidazol-2-one derivatives and their use |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002959A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 01/08/2004 | WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002943A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 01/08/2004 | WO2004002941A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
| 01/08/2004 | WO2004002551A2 Inhalable epinephrine |
| 01/08/2004 | WO2004002549A1 Use of organic compounds |
| 01/08/2004 | WO2004002537A1 Worming formulation |
| 01/08/2004 | WO2004002535A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002531A1 Remedies for diseases caused by vascular contraction or dilation |
| 01/08/2004 | WO2004002530A1 Remedy for chronic disease |
| 01/08/2004 | WO2004002528A1 Compositions and methods for therapeutic treatment |
| 01/08/2004 | WO2004002517A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002516A1 Diagnostics/preventives/re medies for respiratory diseases |
| 01/08/2004 | WO2004002515A1 Diagnostics/preventives/remedies for respiratory diseases |
| 01/08/2004 | WO2004002512A1 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 01/08/2004 | WO2004002505A1 Compositions against inflammatory processes |
| 01/08/2004 | WO2004002500A1 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 01/08/2004 | WO2004002499A1 Drug for prevention and/or treatment of constipation and symptom caused by constipation |
| 01/08/2004 | WO2004002498A1 Antiviral regimens |
| 01/08/2004 | WO2004002497A1 Glycoalkaloid compositions and various uses thereof |
| 01/08/2004 | WO2004002496A1 Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation |
| 01/08/2004 | WO2004002495A1 Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
| 01/08/2004 | WO2004002494A1 Composition for preventing or treating degenerative brain diseases comprising a hydrolysate of ginsenosides |
| 01/08/2004 | WO2004002493A1 Erythropoietin production potentiator |
| 01/08/2004 | WO2004002492A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | WO2004002490A2 Piperidine compounds as antibacterials |
| 01/08/2004 | WO2004002489A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 01/08/2004 | WO2004002488A1 Therapeutic agent for brain hemorrhage |
| 01/08/2004 | WO2004002487A1 Methods for treating attention deficit disorder |
| 01/08/2004 | WO2004002486A2 Ciprofloxacin hci |
| 01/08/2004 | WO2004002485A1 Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2004002482A2 2-pyridin acetic acid derivatives with antiproliferative activity |
| 01/08/2004 | WO2004002481A1 Aryl carbonyl derivatives as therapeutic agents |
| 01/08/2004 | WO2004002480A1 Novel glucagon antagonists/inverse agonists |
| 01/08/2004 | WO2004002479A1 Glycoloyl-substituted oxazolidinone-derivatives as antibacterial agents |
| 01/08/2004 | WO2004002478A1 Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere |
| 01/08/2004 | WO2004002477A1 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 01/08/2004 | WO2004002475A1 Sustained release tablet containing indapamide |
| 01/08/2004 | WO2004002474A1 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/08/2004 | WO2004002473A1 Drug composition for blood sugar control |
| 01/08/2004 | WO2004002472A1 Carvedilol hydrobromide |
| 01/08/2004 | WO2004002471A1 Composition comprising phenolic compound for preventing and treating liver cirrhosis |
| 01/08/2004 | WO2004002470A1 Compounds useful for the inhibition of aldh |
| 01/08/2004 | WO2004002468A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/08/2004 | WO2004002467A1 Peritoneal dialysate containing taurine |
| 01/08/2004 | WO2004002466A1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant |
| 01/08/2004 | WO2004002465A1 DRUG COMPOSITION CONTAINING NF-κB INHIBITOR |
| 01/08/2004 | WO2004002464A1 Antifungal agents for external use |
| 01/08/2004 | WO2004002463A2 Method of promoting smoking cessation |
| 01/08/2004 | WO2004002462A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 01/08/2004 | WO2004002461A2 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 01/08/2004 | WO2004002460A1 Infused wound care dressings |
| 01/08/2004 | WO2004002458A1 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
| 01/08/2004 | WO2004002456A1 Biodegradable block copolymeric compositions for drug delivery |
| 01/08/2004 | WO2004002455A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | WO2004002454A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | WO2004002450A1 Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
| 01/08/2004 | WO2004002448A1 Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition |
| 01/08/2004 | WO2004002447A2 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 01/08/2004 | WO2004002446A1 Composition and method for cessation of nicotine cravings |